We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,143.00
Bid: 7,142.00
Ask: 7,144.00
Change: 133.00 (1.90%)
Spread: 2.00 (0.03%)
Open: 7,001.00
High: 7,172.00
Low: 6,970.00
Yest. Close: 7,010.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

CORRECTED-UPDATE 3-Cold chain doubts delay COVID-19 vaccinations in some German cities

(Corrects to BioNtech spokeswoman, not Pfizer, paragraphs 4-5)By Arno SchuetzeFRANKFURT, Dec 27 (Reuters) - Germany's coronavirus vaccination campaign faced delays in several cities on Sunday after temperature trackers showed that about 1,000 of th...

27 Dec 20 15:38

Sunday newspaper round-up: AstraZeneca, Boxing Day, Britain's economy

(Sharecast News) - The chief executive of AstraZeneca has raised hopes its vaccine with Oxford is more effective than first thought amid the rapid spread of the new UK virus strain across the globe. Pascal Soriot said he believed researchers had found the "winning formula" using two doses and promised to publish the results as reports suggested the UK regulator could approve the jab within days. - Sunday Telegraph

27 Dec 20 12:39

WRAPUP 3-'The beginning of the end': Europe rolls out vaccines to fight pandemic

(Adds quotes from Macron, Greece, Norway, detail and background on new variants, German glitches)* Goal is to offer vaccine to all adults through 2021* EU has secured contracts for 2 billion-plus doses* Frontline workers and elderly among those prio...

27 Dec 20 10:17

WRAPUP 4-'The beginning of the end': Europe rolls out vaccines to fight pandemic

(Adds detail on German delays, detail, background, edits)* Goal is to offer vaccine to all adults through 2021* 'Thank God,' says first recipient in Spain, 96* Delays in some German cities over cooling concerns* Urgency as new virus variants crop upB...

27 Dec 20 10:17

WRAPUP 5-'We have a new weapon': Europe rolls out vaccines in bid to slay COVID

(Adds BioNTech response to German districts, Dutch delay in inoculations)* Goal is to offer vaccine to all adults through 2021* 'Thank God,' says first recipient in Spain, 96* Delays in some German cities over cooling concerns* Urgency as new virus ...

27 Dec 20 10:17

WRAPUP 6-'We have a new weapon': Europe rolls out vaccines in bid to slay COVID

(Adds comment from Pfizer, BioNTech)* Goal is to offer vaccine to all adults through 2021* 'Thank God,' says first recipient in Spain, 96* Delays in some German cities over cooling concerns* Urgency as new virus variants crop upBy Isla Binnie and Gis...

27 Dec 20 10:17

CORRECTED-WRAPUP 6-'We have a new weapon': Europe rolls out vaccines in bid to slay COVID

(Corrects source to BioNTech, not Pfizer, paragraphs 14-15)* Goal is to offer vaccine to all adults through 2021* 'Thank God,' says first recipient in Spain, 96* Delays in some German cities over cooling concerns* Urgency as new virus variants crop u...

27 Dec 20 10:17

AstraZeneca Chief Believes Vaccine Will Work Against UK Virus Strain

AstraZeneca Chief Believes Vaccine Will Work Against UK Virus Strain

27 Dec 20 09:57

UK to roll out Oxford COVID-19 vaccine from Jan. 4, Sunday Telegraph says

LONDON, Dec 26 (Reuters) - The United Kingdom will roll out Oxford University’s COVID-19 vaccine from Jan. 4, according to plans being drawn up by ministers, The Sunday Telegraph reported.The government hopes to give the first dose of either the ...

26 Dec 20 22:11

UPDATE 3-Japan's Suga urges citizens to have a quiet and distanced New Year

(Recasts with Suga, Omit comments)By Kiyoshi Takenaka and Tetsushi KajimotoTOKYO, Dec 25 (Reuters) - Japanese Prime Minister Yoshihide Suga urged the nation on Friday to spend a quiet New Year period without the usual social gatherings to prevent t...

25 Dec 20 04:37

UPDATE 4-Japan's Suga urges citizens to have a quiet and distanced New Year

(Updates with reports on first cases of mutated coronavirus)By Kiyoshi Takenaka and Tetsushi KajimotoTOKYO, Dec 25 (Reuters) - Japanese Prime Minister Yoshihide Suga urged the nation on Friday to spend a quiet New Year period without the usual soci...

25 Dec 20 04:37

UPDATE 5-Japan's Suga urges citizens to have a quiet and distanced New Year

(Updates with health minister confirmation on new variant cases)By Kiyoshi Takenaka and Tetsushi KajimotoTOKYO, Dec 25 (Reuters) - Japanese Prime Minister Yoshihide Suga urged the nation on Friday to spend a quiet New Year period without the usual...

25 Dec 20 04:37

UPDATE 1-More than 600,000 people in UK get first Pfizer COVID-19 vaccine dose

(Adds details from statement, vaccine-related background)Dec 24 (Reuters) - More than 600,000 people in the United Kingdom have received the first dose of the Pfizer-BioNTech COVID-19 vaccine since inoculations began in the country earlier this mo...

24 Dec 20 20:41

UPDATE 1-Turkey says COVID-19 vaccine from China's Sinovac 91.25% effective

(Adds quotes, details, background)ANKARA, Dec 24 (Reuters) - A COVID-19 vaccine developed by China's Sinovac Biotech is 91.25% effective, according to interim data from a late-stage trial in Turkey, a potentially much better result than reported f...

24 Dec 20 18:25

UPDATE 2-Turkey says China's Sinovac COVID vaccine 91.25% effective in late trials

* Turkey is second trial site to report results for Sinovac's shot* Late-stage interim results show 91.25% efficacy for CoronaVac* Turkey says it will receive first shipment from China on Monday* Turkey will also buy 4.5 mln doses of Pfizer/BioNTe...

24 Dec 20 18:25

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.